scPharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch SCPH and buy or sell other stocks, ETFs, and their options commission-free!About SCPH
scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. The firm's products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure.
CEOMichael E. Castagna, MBA
CEOMichael E. Castagna, MBA
Employees164
Employees164
HeadquartersBurlington, Massachusetts
HeadquartersBurlington, Massachusetts
Founded2013
Founded2013
Employees164
Employees164
SCPH Key Statistics
Market cap302.16M
Market cap302.16M
Price-Earnings ratio-3.13
Price-Earnings ratio-3.13
Dividend yield—
Dividend yield—
Average volume1.47M
Average volume1.47M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.28
52 Week high$6.28
52 Week low$1.94
52 Week low$1.94
Stock Snapshot
As of today, scPharmaceuticals(SCPH) shares are valued at $5.67. The company's market cap stands at 302.16M, with a P/E ratio of -3.13.
scPharmaceuticals(SCPH) stock opened on 2025-11-05 at —. The price climbed to — and dipped to —.
The scPharmaceuticals(SCPH)'s current trading volume is 0, compared to an average daily volume of 1.47M.
In the last year, scPharmaceuticals(SCPH) shares hit a 52-week high of $6.28 and a 52-week low of $1.94.
In the last year, scPharmaceuticals(SCPH) shares hit a 52-week high of $6.28 and a 52-week low of $1.94.
People also own
Based on the portfolios of people who own SCPH. This list is generated using Robinhood data, and it’s not a recommendation.